Vaccine Research Program (VRP)
The discovery and development of an HIV/AIDS vaccine for the prevention of HIV infection is one of the top priorities at the NIAID. As such, the DAIDS Vaccine Research Program (VRP), which is divided into the Preclinical Research and Development Branch and Vaccine Clinical Research Branch, supports basic, preclinical, and clinical research of candidate vaccines through the following activities:
-
Oversees grants, contracts, and cooperative agreements that support preclinical and clinical vaccine research, including the HIV Vaccine Trials Network (HVTN) and Center for HIV/AIDS Immunology (CHAVI)
-
Fosters evaluation of the safety and efficacy of vaccine candidates
-
Promotes research programs to discover novel vaccine strategies for the treatment of HIV
-
Coordinates research activities in consultation and/or collaboration with other government agencies, international organizations, and other Institutes at the National Institutes of Health.
-
Works with the pharmaceutical industry and the Food and Drug Administration to facilitate the evaluation and approval of new vaccines
-
Provides scientific guidance to grantees and contractors
For more information on NIAID’s HIV vaccine research efforts, visit the HIV/AIDS Vaccine Research Area.
back to top